quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:17·13h
SECFiling
Dyne Therapeutics Inc. logo

SEC Form DEF 14A filed by Dyne Therapeutics Inc.

DYN· Dyne Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • DYN
    Dyne Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Dec 10UpdateOppenheimer$40.00
  • Oct 10UpdateOppenheimer-
  • Aug 25UpdateRaymond James$35.00
  • Jun 24UpdateBernstein$13.00
  • Jun 11UpdateRaymond James$37.00
  • Jun 2UpdateOppenheimer$34.00

Related

  • SEC13h
    SEC Form 144 filed by Dyne Therapeutics Inc.
  • SEC13h
    SEC Form 144 filed by Dyne Therapeutics Inc.
  • SEC13h
    SEC Form 144 filed by Dyne Therapeutics Inc.
  • INSIDER13h
    Director Kersten Dirk sold $219,170 worth of shares (10,952 units at $20.01) as part of a pre-agreed trading plan (SEC Form 4)
  • SEC13h
    SEC Form DEFA14A filed by Dyne Therapeutics Inc.
  • PR13h
    Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • INSIDER1d
    SEC Form 4 filed by Rhodes Jason P
  • SEC1d
    SEC Form 144 filed by Dyne Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022